Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-187646
Filing Date
2026-04-28
Accepted
2026-04-28 17:02:34
Documents
21
Period of Report
2026-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A iron-20260428.htm   iXBRL DEF 14A 2216828
2 GRAPHIC img49179684_0.jpg GRAPHIC 768569
3 GRAPHIC img49179684_1.jpg GRAPHIC 768569
4 GRAPHIC img49179684_2.gif GRAPHIC 67938
5 GRAPHIC img49179684_3.gif GRAPHIC 71537
6 GRAPHIC img49179684_4.gif GRAPHIC 150492
7 GRAPHIC img49179684_5.gif GRAPHIC 146564
8 GRAPHIC img49179684_6.gif GRAPHIC 103483
9 GRAPHIC img49179684_7.jpg GRAPHIC 161569
10 GRAPHIC img49179684_8.jpg GRAPHIC 153408
  Complete submission text file 0001193125-26-187646.txt   9197323

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT iron-20260428.xsd EX-101.SCH 11699
24 EXTRACTED XBRL INSTANCE DOCUMENT iron-20260428_htm.xml XML 371456
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851612845 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39438 | Film No.: 26909035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)